ceo @ y-trap, advisor @ centivax | previously: herophilus, distributed bio, stanford, gilman

San Francisco, CA
Pinned Tweet
Replying to @rishibedi
This is what makes coding agents powerful: tight loops between proposal, execution, error signal, and revision. Drug discovery needs the same loop: perturb disease-relevant systems → measure state changes → train models → choose the next perturbation. This is what we need to make better biological bets, not just faster molecules. (5/5) rishibedi.com/posts/ai-drug-…
1
4
33
3,575
concrete work that moves the needle for lean teams moving drugs into the clinic, great work from the edison team accelerating a critical and often thankless part of the process
There's been a lot of hand-waving arguments about how AI will accelerate drug discovery. Here's a concrete 3-month reduction in a real example that accelerated a drug program. It's not thrilling like discovering better targets (which we're working on), but I'm happy with it
3
248
i've tried a bunch of ai assistants in the last ~year. dots blows them all out of the water by being connected to codex and being able to access context about all my work. this has been a very productive evening.
72
"proving out unique biological hypotheses" is the interesting part of Max's thread, but the rest of the narrative is focused on claiming "exquisite engineering" of a more developable candidate for a known target. demonstrating that this engineering is actually enabling unique biological hypotheses will determine Iso's impact
Replying to @maxjaderberg
This is one example but we’ve seen this sort of success dozens of times at this point from our engine: unlocking exquisitely engineered molecule designs and proving out unique biological hypotheses in the lab. And pushing hard to show the translation into the clinic to benefit patients. (4/5)
1
1
453
Rishi Bedi retweeted
As someone who did this kind of genome mining work during my PhD, some thoughts on this Anthropic announcement: First, the very simplified version of what they did is that they noticed two genes (one known, one new) sitting next to a weird repeating piece of DNA. More specifically, they described an unusual reverse transcriptase (RT) associated with a repetitive DNA array and an unknown accessory protein. This kind of process was used to understand CRISPR back in 2002 and was key to the gene editing tools we use today. To put this into context, though, people have been finding RTs associated with CRISPR arrays since 2008, and this general kind of genome-neighborhood mining has been used to discover new biological systems for decades. The basic genome-mining strategy is well established, and there are now mature tools and published pipelines for doing much of this. There are papers that discover and experimentally validate dozens of new systems using this approach in a single study. Doing it in bacteriophage genomes is also nothing new (eg CasPhi). Finding a weird cluster of genes and repeats is often the easy part. The hard part, and where the real discoveries come from, is figuring out what the system actually does. Eg for the bridge-RNA discovery in 2024 from @arcinstitute or the discovery of CasPhi in 2020 from @DoudnaJennifer they figured out the pieces of the system and the rules for what makes it work so it can be used. Anthropic does not yet know what this does. They’ve shown that the repeat array produces RNAs, but not what those RNAs do, what the RT does with them, or whether the system has any of the programmable properties that make the CRISPR comparison justified. I’m genuinely rooting for all of the frontier labs to seriously get into biological discovery, and I’m excited about what comes out of it. But announcing these very early, incremental findings with the framing of a major discovery doesn’t help. I’d much rather they set the bar high now, so that when an AI actually discovers a fundamentally new biological mechanism, everyone appreciates how big a deal it is.
Claude has discovered a previously unknown enzyme system hidden in the DNA of bacteriophages. Beside the enzyme’s gene sits a long array of repeating DNA—a structure that looks somewhat similar to CRISPR. We don’t yet understand what this system does, but only a handful of known systems share its features, and all of them are able to cut, copy, and paste DNA. Historically, the discovery of such programmable systems has helped revolutionize medicine. CRISPR, for instance, is now the foundation of genetic medicines. But it will take much more work to learn what this system does, and whether it can be put to similar use. Read more: anthropic.com/news/claude-di…
120
673
4,708
512,846
"violated its own AI policy" misses the point. "additional training for all staff" won't fix the insidious yearning for performative diversity that thrives in the abyss of make-work bureaucracy. the real story is: "administrator whose job shouldn't exist at all does dumb thing"
Stanford University confirmed it violated its owns AI policy by turning a Hispanic student into a fake Black woman in a dining hall ad. It also modified the faces of two other students sfchronicle.com/bayarea/arti…
6
510
Rishi Bedi retweeted
very cool result showing how wet lab data enables a specialized model to beat gpt-6 astra at a task at the frontier of science! in general scaling is great and obviously i am a believer in it, but probably the more we approach the frontier of science, the more specialized data matters and that gives task-specific models a chance. this specialized data is usually private and is probably a real moat it should be in principle true that a task specific model will probably do better at scientific discovery just because it can use more of its parameters for the task you care about
We built high-throughput materials labs in Menlo Park to create a loop between experiments and models. The labs generate fresh data, the models learn from it, and then help us decide what to try next. Using only 1,300 H200s, plus months of our experimental data, we mid-trained and RL’d an open-source model to surpass GPT-6 Astra on our analysis benchmark. We call it Neon. This is real footage from our lab. We’re focusing first on hard problems in materials science, including superconductors, magnets, and semiconductor materials. Read our blog posts below.
14
10
207
40,064
open-sourcing CTDs is extremely exciting. we have found clinical protocols available on clinicaltrials.gov to be extremely helpful at y-trap. this will be an OOM jump beyond that in utility, especially for lean teams without decades of regulatory experience.
Replying to @JacobTref
CTD Commons will preserve and publish regulatory knowledge from failed drug development programs so future teams can learn from precedent that is usually locked away, to help uncover effective treatments for patients faster. A CTD, or Common Technical Document, is a document that compiles the full journey of an investigational drug – everything from animal toxicology, manufacturing details, and, perhaps most usefully, correspondence with the FDA. Yet only a small fraction of that work appears in published papers. CTD Commons will test the possibility of acquiring CTDs from failed or shelved drug programs, and make them openly available for research and analysis, for everyone to use. @antonioregalado wrote about the project, and @RuxandraTeslo's essay on the topic, here: nitter.net/antonioregalado/status…
2
8
583
Rishi Bedi retweeted
I must be among an extremely small group of people (n=1?) that have both 1) trained a frontier LLM and 2) designed and synthesized custom viruses in a lab with my own two hands. And I think that the takes on AI killing us all by creating dangerous viruses is total bogus.
573
1,908
14,436
1,936,915
Rishi Bedi retweeted
Mathematics has now fully morphed into biology: Project costs millions $ ✅ Put out paper that nobody has read ✅ Massive paper supplement nobody will read ✅ Advertise with pretty art ✅ Vicious authorship fight ✅ Say you're curing cancer ✅
45
637
7,863
229,881
Rishi Bedi retweeted
We’re sharing a solution to the Navier-Stokes Millennium Prize Problem, one of the deepest problems at the frontier of mathematics. The proof was produced by a group of agents, using an OpenAI next-generation model significantly more capable than GPT-6 Astra. The problem concerns whether the description of smooth three-dimensional fluid motion modeled by the Navier-Stokes equations can break down. It has remained unresolved for roughly 90 years.
5,709
20,142
120,517
74,981,882
From a YC-backed healthtech launch this week: "ILLUSTRATIVE RECORD · NO PHI" beneath a fictional marketing graphic. Obvious AI slop. It’s like a bank bragging that the fake account statement in its ad has "NO REAL CUSTOMER ACCOUNT NUMBERS": meaningless. I have nothing against AI-generated website or marketing copy in general. But used indiscriminately, it gives off strong "safety theater" vibes which is a bad look in healthcare and biotech. The problem isn't just bad copy - it suggests that the people running the business don't understand the actual risk profile for their patients... and are instead using nonsense slogans to put on an (amateurish) performance of safety.
2
140
it is very exciting for codex et al. to obviate the need for scientists to look at every line of code analyzing their data do not let this lull you into not looking at the _data_
2
143
noticed for the first time today agents in codex communicating with each other; happened automatically when i tagged one active task in another "Sent by ChatGPT from another task"
1
155
Rishi Bedi retweeted
> "what's the easiest way to fix our comms issues?" > "maybe we should just cure cancer"
Anthropic has told investors in pre-IPO meetings that it plans to lean harder into biology and healthcare applications to help mitigate the increasingly negative public sentiment against the industry. A few miracle cures would certainly do wonders to turn things around.
18
41
1,585
73,376
Elegant demonstration that immune cells from the periphery infiltrate the aging brain. The possibility that modulating peripheral immunity could affect neurodegenerative disease opens up a whole new control surface for therapeutic intervention.
Gaining therapeutic access to the human brain is one of the biggest unsolved problems in biomedical science. Today @nature, we uncover a massive influx of immune cells into the human brain during aging, revealing that the brain is more accessible than previously thought. 1/ nature.com/articles/s41586-0…
1
2
10
1,542
Rishi Bedi retweeted
Catching skin cancer early is a home robotics problem. Melanoma is highly treatable when detected early, yet today’s screening process depends heavily on patients noticing tiny changes across their entire skin surface. This requires patients to solve a near-impossible visual-memory and registration problem. I built OpenDerm, an open-source 4-DOF robot that captures high-resolution images of the skin and uses them to reconstruct and track the skin surface in 3D over time. The best way to make skin screening truly routine is to bring it into the home. OpenDerm shows that inexpensive robotic skin imaging is possible, but the path to scale is not a dedicated screening robot in every household—it is to make skin screening one of the many useful things a general-purpose home robot can do. Read more about why I built OpenDerm and how it works here: Blog: marionlepert.github.io/blog/… Project: openderm.github.io/
416
978
9,064
1,505,491
besides how awesome it is that a century-old conjecture is disproven by LLM, it is also very cool to see mathematics-in-public on X: open discourse from experts on how to interpret/contextualize/generalize the result
hello there the jacobian conjecture is false thanx to my close friend akhil for asking about it and my other close friend fable for working during the world cup final ((1+xy)^3 z + y^2 (1+xy) (4+3xy), y + 3 x (1+xy)^2 z + 3 x y^2 (4+3xy), 2 x - 3 x^2 y - x^3 z): \C^3\to \C^3, has jacobian determinant -2, and sends (0, 0, -1/4), (1, -3/2, 13/2), and (-1, 3/2, 13/2) to (-1/4, 0, 0)
2
236
delighted by the fact that starting a codex-app project in an ssh remote directory automatically picks up (and nicely renders) existing codex-cli sessions in that directory!
3
525
Very excited about 5.6-sol but so far, almost every request (including non-bio) I have submitted in Codex has triggered the following: "This request requires additional safety checks, which can take extra time. Hang tight or retry with a faster model for a quicker response, though it may be less capable of handling complex requests." 1/ It is opaque as to how long these safety checks will take, so I have no idea how much of a time penalty I'm paying by sticking with sol. 2/ Beware that on long-running tasks, "retrying with a faster model" discards progress/context -> re-starts from scratch with luna. This is much better than Fable's complete nerf-ing at the briefest mention of biology, but still annoying.
3
767
Most drugs don’t fail because we can’t build the molecule. They fail because we asked the molecule to do the wrong thing. Fixing this is the great frontier for AI in biology. (1/5)
6
17
163
20,342
AI can help solve this, but only if it gets access to the thing biology is short on: causal feedback. Plausible mechanisms are cheap. Causal evidence about what actually moves a disease state is scarce. (4/5)
1
1
9
1,342
This is what makes coding agents powerful: tight loops between proposal, execution, error signal, and revision. Drug discovery needs the same loop: perturb disease-relevant systems → measure state changes → train models → choose the next perturbation. This is what we need to make better biological bets, not just faster molecules. (5/5) rishibedi.com/posts/ai-drug-…
1
4
33
3,575